Dense deposit disease.
Smith RJ, Harris CL, Pickering MC.
Mol Immunol. 2011 Aug;48(14):1604-10. doi: 10.1016/j.molimm.2011.04.005. Epub 2011 May 24.
C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.
Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.
C3 Glomerulopathy: Pathogenesis and Treatment.
Ahmad SB, Bomback AS.
Adv Chronic Kidney Dis. 2020 Mar;27(2):104-110. doi: 10.1053/j.ackd.2019.12.003.
Dense deposit disease: new insights.
Walker PD.
Curr Opin Nephrol Hypertens. 2007 May;16(3):204-12. doi: 10.1097/MNH.0b013e3280bdc0f4.
Dense deposit disease and C3 glomerulopathy.
Barbour TD, Pickering MC, Terence Cook H.
Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002.
Primary glomerulonephritides.
Floege J, Amann K.
Lancet. 2016 May 14;387(10032):2036-48. doi: 10.1016/S0140-6736(16)00272-5. Epub 2016 Feb 25.
Dense Deposit Disease Mimicking a Renal Small Vessel Vasculitis.
Singh L, Singh G, Bhardwaj S, Sinha A, Bagga A, Dinda A.
J Am Soc Nephrol. 2016 Jan;27(1):59-62. doi: 10.1681/ASN.2015020187. Epub 2015 Sep 11.
Drusen in Dense Deposit Disease.
Mammo DA, Roizenblatt R.
Ophthalmology. 2021 Aug;128(8):1221. doi: 10.1016/j.ophtha.2021.02.009.
C4 dense-deposit disease.
Sethi S, Sullivan A, Smith RJ.
N Engl J Med. 2014 Feb 20;370(8):784-6. doi: 10.1056/NEJMc1309449.
Complement dysregulation in glomerulonephritis.
Kaartinen K, Safa A, Kotha S, Ratti G, Meri S.
Semin Immunol. 2019 Oct;45:101331. doi: 10.1016/j.smim.2019.101331. Epub 2019 Nov 9.
